The global fibroblast growth factors (FGFs) market is poised for significant expansion over the next decade, as increasing research in regenerative medicine and expanding applications in wound healing and tissue engineering drive robust demand. According to the latest market insights, the global FGFs industry was valued at US$ 270.7 million in 2023 and is expected to register a compound annual...